Pearl River Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,810
Closed -$494K 546
2022
Q3
$494K Buy
+2,810
New +$575K 0.09% 289
2022
Q2
Sell
-8,231
Closed -$1.86M 511
2022
Q1
$1.86M Sell
8,231
-8,467
-51% -$1.99M 0.51% 54
2021
Q4
$4.51M Buy
16,698
+6,568
+65% +$1.63M 1.22% 8
2021
Q3
$2.45M Buy
+10,130
New +$2.55M 0.67% 28
2021
Q1
Sell
-2,098
Closed -$367K 462
2020
Q4
$367K Buy
+2,098
New +$362K 0.13% 242
2020
Q3
Sell
-4,337
Closed -$619K 415
2020
Q2
$619K Buy
4,337
+4,105
+1,769% +$568K 0.31% 103
2020
Q1
$25K Sell
232
-8,776
-97% -$1.26M 0.05% 302
2019
Q4
$1.31M Buy
9,008
+8,304
+1,180% +$1.2M 0.49% 27
2019
Q3
$102K Buy
+704
New +$103K 0.29% 134

Other funds holding LH

Pearl River Capital's LH Position: Q4 2022 in Review

Pearl River Capital sold out of Labcorp (LH) in Q4 2022, closing a stake of 2,810 shares — an estimated $494K sold.

Pearl River Capital first reported a position in LH in Q3 2019 and held it in 9 quarters. The position peaked at $4.51M in Q4 2021. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Pearl River Capital reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Pearl River Capital sold 2,810 Labcorp shares in Q4 2022, an estimated $494K.
  • Pearl River Capital first reported a position in Labcorp in Q3 2019 and held it in 9 quarters.
  • Pearl River Capital's Labcorp position peaked at $4.51M in Q4 2021.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.